Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study
Stock Information for Cardiff Oncology Inc.
Loading
Please wait while we load your information from QuoteMedia.